Foto del docente

Fabrizio De Ponti

Professore ordinario

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIO/14 FARMACOLOGIA

Pubblicazioni

Giovanni Dothel; Valentina Vasina; Giovanni Barbara; Fabrizio De Ponti, Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues, «PHARMACOLOGY & THERAPEUTICS», 2013, 139, pp. 71 - 86 [articolo]

Raschi E.; Piccinni C.; Poluzzi E.; Marchesini G.; De Ponti F., The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database., «ACTA DIABETOLOGICA», 2013, 50, pp. 569 - 577 [articolo]

Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden., «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2013, 69, pp. 715 - 720 [articolo]

Mariam Molokhia;Fabrizio De Ponti;Elijah R Behr;Gianluca Trifirò;Miriam Sturkenboom, Academic output from EU-funded health research projects, «THE LANCET», 2012, 380, pp. 1903 - 1904 [replica/breve intervento]

Raschi E.; De Ponti F., Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology., «INTERNAL AND EMERGENCY MEDICINE», 2012, 7, pp. 113 - 131 [articolo]

B. Balestra;R. Vicini;C. Cremon;L. Zecchi;G. Dothel;V. Vasina;R. De Giorgio;A. Paccapelo;O. Pastoris;V. Stanghellini;R. Corinaldesi;F. De Ponti;M. Tonini;G. Barbara, Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons, «NEUROGASTROENTEROLOGY AND MOTILITY», 2012, 24, pp. 1118 - 1125 [articolo]

Elisabetta Poluzzi; Emanuel Raschi; Carlo Piccinni; Fabrizio De Ponti, Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS), in: Data Mining Applications in Engineering and Medicine, RIJEKA, InTech, 2012, pp. 265 - 302 [capitolo di libro]

Vasina V; Giannone F; Domenicali M; Latorre R; Berzigotti A; Caraceni P; Zoli M; De Ponti F; Bernardi M., Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A., «BRITISH JOURNAL OF PHARMACOLOGY», 2012, 167, pp. 1137 - 1147 [articolo]

De Ponti F; Mugelli A, Tra linee guida e decisioni regolatorie: l'odissea del dronedarone, «GIORNALE ITALIANO DI CARDIOLOGIA», 2012, 13, pp. 334 - 336 [replica/breve intervento]

Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A.; De Ponti F.; Montanaro N., Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2011, 67, pp. 407 - 414 [articolo]

Ursino M.G.; Poluzzi E.; Caramella C.; De Ponti F., Excipients in medicinal products used in gastroenterology as a possible cause of side effects., «REGULATORY TOXICOLOGY AND PHARMACOLOGY», 2011, 60, pp. 93 - 105 [articolo]

Maselli M.A.; Trisolini P.; Demma I.; Pezzolla F.; De Ponti F., Gender- and age-related differences in muscular and nerve-mediated responses in human colon, «DIGESTIVE DISEASES AND SCIENCES», 2011, 56, pp. 352 - 358 [articolo]

Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G., Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome., «AMERICAN JOURNAL OF GASTROENTEROLOGY», 2011, 106, pp. 1290 - 1298 [articolo]

Raschi E; Poluzzi E; Koci A; Boriani G; De Ponti F., QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2011, 72, pp. 839 - 841 [replica/breve intervento]

Raschi E.; Boriani G.; De Ponti F., Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling, «CURRENT DRUG TARGETS», 2011, 12, pp. 263 - 286 [articolo]